Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

COVID-19 Endoscopy Survey (COVID-19 Endo)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04342637
Recruitment Status : Completed
First Posted : April 13, 2020
Last Update Posted : May 20, 2020
Sponsor:
Information provided by (Responsible Party):
Mohamed Alboraie, Al-Azhar University

Brief Summary:
A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of GI endoscopy practice in the studied countries.

Condition or disease Intervention/treatment
COVID-19 Other: Practice details

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 163 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Gastrointestinal Endoscopy in the Era of COVID-19: a Multinational Survey
Actual Study Start Date : April 10, 2020
Actual Primary Completion Date : April 25, 2020
Actual Study Completion Date : May 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy

Group/Cohort Intervention/treatment
Practicing gastroenterologists
Practicing physicians performing gastrointestinal endoscpy
Other: Practice details
Physicians will report details of their endoscopy practice through answering the questions of the questionnaire




Primary Outcome Measures :
  1. Effect of GI societies recommendations on prevention of SARS-CoV-2 infection [ Time Frame: 4- 6 months ]
    To evaluate the validity of different GI societies recommendations applied locally and how effective they are in preventing transmission in endoscopy units through reporting any new cases developing COVID-19 within two weeks of doing endoscopy (whether a patient or health-care worker)

  2. To measure the percentage change in performed endoscopic procedure in response to COVID-19 [ Time Frame: 4- 6 months ]
    To measure the percentage change in performed endoscopic procedure in response to COVID-19 in different centers of the world and the alternative solutions given to overcome this problem.


Secondary Outcome Measures :
  1. Effect of COVID-19 precautions on procedure time [ Time Frame: 4- 6 months ]
    Effect of COVID-19 precautions on procedure time

  2. Effect of COVID-19 precautions on time of disinfection [ Time Frame: 4- 6 months ]
    Effect of COVID-19 precautions on prolongatIon of time of disinfection

  3. Effect of COVID-19 precautions on procedure success [ Time Frame: 4- 6 months ]
    Effect of COVID-19 precautions on the ability of the endoscopist to finish the procedure successfully

  4. Effect of COVID-19 precautions on complications [ Time Frame: 4- 6 months ]
    Effect of COVID-19 precautions on occurrence of complications

  5. Effect of COVID-19 precautions on working time [ Time Frame: 4- 6 months ]
    Effect of COVID-19 precautions on change of working time (prolongation or shortening)

  6. Effect of COVID-19 precautions on staff number [ Time Frame: 4- 6 months ]
    Effect of COVID-19 precautions on change of staff number



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
- physicians working and practicing in gastrointestinal endoscopy units worldwide
Criteria

Inclusion Criteria:

  • physicians working in endoscopy units worldwide

Exclusion Criteria:

  • physicians not working in endoscopy units worldwide

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04342637


Locations
Layout table for location information
United States, New York
Kings County Hospital Center, Brooklyn, NY, USA
Albertson, New York, United States, 11507
Egypt
Faculty of Medicine, Zagazig University
Zagazig, Sharkia, Egypt, 44519
Al-Azhar Univerisity
Cairo, Egypt, 11651
Iran, Islamic Republic of
Ahvaz Imam hospital
Ahvaz, Iran, Islamic Republic of, 6155873559
Sponsors and Collaborators
Al-Azhar University
Additional Information:
Publications of Results:

Layout table for additonal information
Responsible Party: Mohamed Alboraie, Lecturer of medicine and gastroenterology, Al-Azhar University
ClinicalTrials.gov Identifier: NCT04342637    
Other Study ID Numbers: WES-2
First Posted: April 13, 2020    Key Record Dates
Last Update Posted: May 20, 2020
Last Verified: May 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: After publication we may share data

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mohamed Alboraie, Al-Azhar University:
Endoscopy
Gastrointestinal
COVID-19
SARS-CoV-2
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases